InvestorsHub Logo
Followers 271
Posts 15407
Boards Moderated 1
Alias Born 03/28/2013

Re: None

Tuesday, 01/11/2022 7:05:51 AM

Tuesday, January 11, 2022 7:05:51 AM

Post# of 458143
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Anavex Life Sciences (AVXL – Research Report) today and set a price target of $39.00. The company's shares closed last Monday at $15.47. According to TipRanks.com, Selvaraju has 0 stars on 0-5 stars ranking scale with an average return of -23.2% and a 21.0% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Aquestive Therapeutics, Oncternal Therapeutics, and Inovio Pharmaceuticals. Currently, the analyst consensus on Anavex Life Sciences is a Strong Buy with an average price target of $39.80, a 164.1% upside from current levels.

https://www.tipranks.com/news/blurbs/anavex-life-sciences-avxl-gets-a-buy-rating-from-h-c-wainwright?utm_source=advfn.com&utm_medium=referral
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News